Moderna Stock Jumps, Continuing Recent Rally

Moderna shares are having their best day in nearly two months. The vaccine developer rose about 8% in morning trading Tuesday. The shares were earlier up 9%, which would mark the stock’s best performance since a 14% advance February 22.